Home

Frank Yocca, Chief Scientific Officer: BioXcel Therapeutics BTAIQ Sell · Filed 24/12/17

Trade details

Type
Insider sale
Amount
$78.75
Shares · price
225 sh · $0.35 a share
Held after
28,931 sh
Trade date
24/12/16
Filed
24/12/17
Days to filing
1 days

Sold 0.8% of holdings

Share of holding sold
0.8%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/16~25/01/15

Frank Yocca's recent trades

  • Frank Yocca

    Sell10b5-1 planBioXcel Therapeutics

    $7,461

    Filed 05/22

  • Frank Yocca

    Planned sale10b5-1 planBioXcel Therapeutics

    $7,430

    Filed 05/20

  • Frank Yocca

    Sell10b5-1 planBioXcel Therapeutics

    $74

    Filed 24/12/17

  • Frank Yocca

    Sell10b5-1 planBioXcel Therapeutics

    $3,946

    Filed 24/10/03

  • Frank Yocca

    Sell10b5-1 planBioXcel Therapeutics

    $245

    Filed 24/09/17

Frank Yocca, Chief Officer — sold $79 of BioXcel Therapeutics BTAIQ · 0.8% of holdings · 10b5-1 plan | Whalegun